Navigating the Challenges of AI in Patient Care and Health Outcomes

Doctors are expressing skepticism about the use of artificial intelligence (AI) in patient care, citing lax rules and a lack of transparency in the approval process. While the FDA has approved numerous AI programs for medical use, physicians are concerned that these tools may not actually improve care or be supported by solid research. The FDA's role in vetting and describing these programs has been criticized, with doctors calling for more confidence in their effectiveness before incorporating them into their workflow. President Biden plans to issue an executive order addressing the regulation of AI in healthcare, including funding for research and a safety program to monitor harm or unsafe practices. The lack of publicly available information about AI programs is causing doctors to be cautious, as they want to avoid unnecessary procedures and higher medical costs without significant improvements in patient care.